Streptozotocin (STZ) is an alkylating agent that targets insulin-producing beta cells in the pancreas, mimicking Type 1 diabetes phenotypes in mice. Propel your preclinical research using on-demand STZ-injected models generated on various genetic backgrounds, as well as additional services available to researchers worldwide.
STZ Induction Statisticsa
Glucose range (mg/dL) |
C57BL/6J | NOD scid | NSG |
---|---|---|---|
250 - 349 | 26% | 14% | 8% |
350 - 449 | 43% | 18% | 32% |
> 450 | 31% | 67% | 57% |
Average Glucose +/- St Dev (# Mice) | 414 +/- 93 (1573) | 484 +/- 92 (49) | 473 +/- 91 (73) |
a Non-fasting glucose was measured 14-16 days after the first injection. Data are for guidance only.
Additional phenotypic data from STZ-induced C57BL/6J, NOD scid, and NSG mice.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.